!
!
Sign in / Join ICS
Home
Patients reporting severe overactive bladder symptoms: Effects of solifenacin treatment on objective measures and patient-reported outcomes
Capo' J P
1
, Toglia M
2
, Forero-Schwanhaeuser S
3
, He W
4
Abstract Category
Detrusor Overactivity
Abstract 582
Read by Title
Scientific Non Discussion Abstract Session 20
1.
Internal Medicine Associates of Atlanta, Atlanta, Georgia, USA,
2.
Urogynecology Associates of Philadelphia, Media, PA, USA,
3.
GlaxoSmithKline, King of Prussia, Pennsylvania, USA,
4.
Astellas Pharma US Inc., Deerfield, IL, USA
Links
Abstract PDF
Edit Abstract
Abstract Centre
Abstract
25/09/2024 13:34:59